A32.1
Listerial meningitis and meningoencephalitis
Clinical Classification Guidelines
Medical Intelligence & Overview
Listerial meningitis and meningoencephalitis are serious infections caused by the bacterium *Listeria monocytogenes*. These infections primarily affect the central nervous system, leading to inflammation of the meninges—the protective membranes covering the brain and spinal cord—or the brain itself in meningoencephalitis. Though relatively rare, these conditions can be life-threatening, especially in vulnerable populations such as the elderly, pregnant women, newborns, and those with weakened immune defenses. Recognizing the symptoms and understanding the causes and treatment options are crucial for timely medical intervention.
Causes & Symptoms
Clinical Causes: Consumption of contaminated food products, including unpasteurized dairy, deli meats, or processed foods. Contact with contaminated soil or water containing *Listeria* bacteria. Transmission from mother to fetus during pregnancy, which can result in severe neonatal infections. Person-to-person spread is uncommon, but the bacteria can occasionally be transmitted through contact with infected individuals. In immunocompromised individuals, *Listeria* can invade the nervous system more readily, leading to meningitis or meningoencephalitis.
Key Symptoms: Fever Headache Stiff neck Sensitivity to light (photophobia) Nausea and vomiting Confusion or altered mental status Seizures (in severe cases) Neck pain Muscle weakness or paralysis In pregnant women, symptoms may be mild but can include flu-like feelings, with risk of transmission to the fetus.
Diagnostic & Treatment
Diagnosis Path: The diagnosis of listerial meningitis or meningoencephalitis involves several steps, including medical history and physical examination. Laboratory tests are essential for confirmation: - **Lumbar puncture (spinal tap)** to obtain cerebrospinal fluid (CSF) for analysis. Typical findings include increased white blood cells, elevated protein levels, and low glucose levels. - **Microbiological cultures** of CSF, blood, or other samples to identify *Listeria monocytogenes*. - **Polymerase chain reaction (PCR)** testing may also be used to detect bacterial DNA. - Imaging studies such as MRI or CT scans can help rule out other causes of neurological symptoms and assess the extent of brain involvement.
Treatment Protocols: Treatment typically involves prompt administration of antibiotics effective against *Listeria monocytogenes*. First-line therapies include: - **Ampicillin** combined with **gentamicin** for synergistic effect. - Alternative antibiotics may be considered in cases of penicillin allergy. Supportive care is vital and may include managing symptoms like fever and dehydration. Patients should be closely monitored for neurological complications. In pregnant women, treatment aims to prevent transmission to the fetus and manage maternal infections. Recovery depends on factors such as the promptness of diagnosis, the patient’s immune status, and the severity of the infection.
Clinical Advice & FAQs
Billing Guidance
Is A32.1 a billable ICD-10 code?
Yes, A32.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A32.1?
Clinical documentation must specify the nature of Listerial meningitis and meningoencephalitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
